[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

What Chronic Lymphocytic Leukemia Patients Should Know about Richter Syndrome with Erin Parry, MD, PhD

What Chronic Lymphocytic Leukemia Patients Should Know about Richter Syndrome with Erin Parry, MD, PhD image

What Chronic Lymphocytic Leukemia Patients Should Know about Richter Syndrome with Erin Parry, MD, PhD

Adult CLL Chapter
event Nov 20, 2024 / 03:00PM - 04:00PM EST
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Richter syndrome, or Richter transformation, is a rare but serious transformation of chronic lymphocytic leukemia to a more aggressive lymphoma. Join us for this virtual webinar with Dr. Erin Parry, a hematologist oncologist specializing in treating and researching chronic lymphocytic leukemia and lymphomas.

Event Highlights

What is Richter Syndrome?

expand_more

Risk Factors for Richter Syndrome

expand_more

Diagnosis and Types of Richter Syndrome

expand_more

Treatment of Transformation

expand_more

Q&A

expand_more

Schedule & Agenda

The panelist Dalton Bean
Introduction
3:00 PM
Dalton Bean

Dalton introduces the agenda of the event and featured speaker Erin Parry, MD, PhD

The panelist Erin Parry, MD, PhD
Presentation
3:05 PM
Erin Parry, MD, PhD

Dr. Erin Parry shares about richter syndrome for chronic lymphocytic leukemia patients

The panelist Audience
Questions and Answers
3:35 PM
Audience

Type your questions in the chat, and Dr. Jacobs will answer them!

Speakers & Moderators

The panelist Erin Parry, MD, PhD
Erin Parry, MD, PhD

Dr. Parry attended Johns Hopkins University School of Medicine where she earned an MD and a PhD. Upon graduation from medical school, Dr. Parry completed residency training in internal medicine at the Johns Hopkins Hospital followed by medical oncology fellowship at Dana-Farber/Partners CancerCare. During her fellowship, Dr. Parry conducted post-doctoral research in the laboratory of Dr. Catherine Wu on Richter transformation of chronic lymphocytic leukemia (CLL). Dr. Parry is currently an Assistant Professor of Medicine at Harvard Medical School and a Physician at Dana-Farber Cancer Institute in the Lymphoma Program and the Center for Chronic Lymphocytic Lymphoma. She runs a laboratory focused on the transformation of indolent B cell malignancies to aggressive lymphoma and mechanisms of immune evasion in CLL and B cell  lymphoma.

Read Bio
The panelist Dalton Bean
Dalton Bean
Lehi, UT

Dalton joined HealthTree in 2024 as the CLL and MF Education Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

newsletter icon

Get the latest thought leadership on your Chronic Lymphocytic Leukemia delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.

Thanks to our HealthTree Community for Chronic Lymphocytic Leukemia Sponsors:

Abbvie
Genentech

Follow Us

facebook instagram youtube